Viracta Therapeutics, Inc. (NASDAQ:VIRX), a pharmaceutical company with a market capitalization of just $6 million, is set to be delisted from the Nasdaq Stock Market LLC, with trading of its common ...

DoubleDragon Corp., the property venture of tycoons Edgar Sia II and Tony Tan Caktiong, has moved a step closer toward ...

Fact checked by Stella Osoba Passive investing has often been a proven winner in the long term, but investors still need to ...

Looking ahead, Nasdaq anticipates growth in its Financial Technology division within the 10-14% range. The company is also targeting a reduction in non-GAAP expenses to between $2.245 billion and ...

Cellectar Biosciences Inc. (NASDAQ:CLRB), a pharmaceutical company with a market capitalization of $10.38 million, has been ...

In a turbulent market session, VIRX, the stock of Sunesis Pharmaceuticals (NASDAQ:VIRX), plummeted to a 52-week low, reaching a distressing price level of $0.08. According to InvestingPro data, the ...

Nasdaq reported a higher fourth-quarter profit on Wednesday, helped by strong demand for the exchange operator's financial ...

The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...

The Texas Stock Exchange (TXSE) is eyeing a 2026 launch after submitting paperwork to operate as a national securities ...

OSLO (Reuters) -Pan-European stock exchange Euronext on Tuesday announced it would acquire Nasdaq's Nordic power futures ...